Imviva Biotech
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A cell and gene therapy company developing next-generation engineered cell therapies for oncology.
Oncology
Technology Platform
Develops cell and gene therapy platforms for engineering immune cells (like CAR-T) with enhanced anti-tumor capabilities and manufacturability.
Opportunities
Potential to develop a differentiated, efficacious cell therapy for solid cancers, a major unmet need.
Risk Factors
Faces significant scientific, manufacturing, and clinical risks associated with complex cell and gene therapy products.
Competitive Landscape
Competes in the fast-evolving global cell therapy arena, requiring breakthroughs in engineering to address solid tumors and off-the-shelf production.